Excellent science and amazing hospitality at the KASL 2024. Grateful to the organizers for the invitation to speak on #masld. Glad to have met friends, both old and new! #livertwitter

Continuing critical hepatology series- here we discuss on ALF-causes, approach, management, and future directions. The Lancet Rakhi Maiwall EASLnews AASLD INASL APASL News The Lancet Gastroenterology & Hepatology Salvatore Piano Juan Pablo (JP) Arab, MD  International Society for Hepatic Encephalopathy Robert Fontana #livertwitter

Awww - all we "liver experts" get SLAMMED by the diagnostic alorithm of sequential NITs 😳👏💥 pubmed.ncbi.nlm.nih.gov/38860621/ roypounder.apt Quentin M. Anstee Stuart Mcpherson #livertwitter

Thanks, Hepatobiliary Surgery and Nutrition for the support

So proud of Ben Koh, Darren Tan , Wen Hui Lim , Jiening and Jieling for winning the Yong Loo Lin School of Medicine research prize 🥳 Cheng Han Ng Mark Muthiah

Great study roypounder.apt Rahul Kumar

Thanks Aleksander Krag for this amazing pic! Appreciate it! The work that I presented included work from several investigators from across the 🌎 Veeral Ajmera Mónica Tincopa MD MSc Daniel Huang Federica Tavaglione Mazen Noureddin, MD, MHSc Vincent Wong AASLD EASLnews APASL News Quentin M. Anstee Maru Rinella MD

Four years of work- Key paper to read Prevalence of steatotic liver disease, advanced fibrosis and cirrhosis among community-dwelling overweight and obese individuals in the USA gut.bmj.com/content/early/… AASLD EASLnews INASL Daniel Huang Federica Tavaglione UCSD Gastroenterology

This Figure shows #MASLD prevalence by GDP per capita in the Asia-Pacific region Find out more in this REVIEW on the burden of liver disease and HCC in the A-P region nature.com/articles/s4157…

Read 'open access': "Enhancing linkage to care for hepatitis B, D, and C patients: A retrospective-prospective study" - bit.ly/4g4xUz2 #livertwitter #HepB #HepC #HepD

Enjoyed co-chairing the multidisciplinary #HCC tumor board organized by GESS, HPB Association SG, Roche, and learning from experts Su Pin Choo DrLeeSerYee piercechow Exciting times for HCC, multidisciplinary care is more important than ever!

New guideline open for public comment: prevention and treatment of hepatitis B virus reactivation in immunosuppressed individuals. Review the recommendations and share any feedback by Sept. 25 ➡️ ow.ly/gPeQ50T7TB0

Happy to share our narrative review of the natural history of MASLD in The Lancet Gastroenterology & Hepatology Link: thelancet.com/journals/langa… Ying Shang Patrik Nasr Hannes Hegmar #LiverTwitter Karolinska Institutet

National Symposium on Translational Research In #HCC Learned a lot from luminaries in the field: Prof Cheng Yale University (developer of Lamivudine for HBV), Holden YC Hsu Tung-Hung Su Teng-Yu Lee James Ou USC Thank you Prof CY Wu for inviting me to lovely #Taipei to speak on MASH HCC!

ITT outcomes of pts with HCC receiving immunotherapy before liver transplant Journal of Hepatology doi.org/10.1016/j.jhep… 🔎🇺🇸VITALITY study 👉86 pts 👉75.6% downstaged 👉36% LTx 👉3-year ITT OS 71.1% 👉 7 rejections, 1 graft lost 🧐More evidence to support ICI before LTx ESMO - Eur. Oncology

Join us at Toronto for ILCA 2024 Daniel Huang Amit G Singal Atoosa Rabiee Andrew Moon BCLC GROUP #livertwitter